Drug May Help Keep Aggressive Prostate Cancer in Check

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.


1 Comment

Fri Jan 25, 2019 04:11 AM

I'm currently on Lupron;  however, it appears to be declining in effectiveness, with my PSA increasing over the last year.  I'm testing every two months and currently at 1.4, the previous tests were .8, .5, .1 respectively.  I've discussed when to progress to either Xtandi or Ztiga with both my urologist and hematologist/oncologist.  They have both suggested that when the PSA reaches 5.0+, scans should be done and treatment progression should probably begin.

I'm wondering if anyone has thoughts as to whether I may be waiting too long to progress to Xtandi or Ztiga. 

You must be logged in to post comments.

We care about your feedback. Let us know how we can improve your CancerCompass experience.